To: Bouf who wrote (119176 ) 3/14/2000 8:17:00 AM From: Lane Hall-Witt Respond to of 119973
WAVX, ORTC, WCAP -- catalysts on the horizonWAVX has declined sharply the past few days since its recent run to 50, but has at least two news events that should be announced soon. (1) Cyber-COMM is expected to launch its European smart-card network this month. Cyber-COMM is a company formed by a large coalition of European financial institutions and technology interests; it has licensed WAVX technology for the reference platform for its smart-card readers and PC keyboards. The rollout this month will be about 20,000 sites. The network is expected to expand to 200,000 sites by the end of 2000 and to 2 million sites by 2002.webfaster.net wave.com (2) WAVX and Atmel are developing the EMBASSY II security chip; it adds broader programmability to WAVX's patented EMBASSY technology. According to the original project timetable, EMBASSY II is expected to be available during this quarter (1Q2000). It was recently demonstrated at a conference sponsored by RSA Data Security.atmel.com wave.com (3) The news all Wavoids anticipate is a major OEM deal with a PC manufacturer. I haven't seen any published evidence that such a contract is imminent, but WAVX has stated that it's in discussions with Compaq, IBM, and Hewlett-Packard. WAVX and Hewlett-Packard have worked especially closely, co-developing a broad strategy for providing client-side security. "Trusted-client" PC solutions (such as EMBASSY) should hit the market by the second half of 2000, according to an interview with WAVX Director of Corporate Communications Aaron Feigin.stockhouse.com wave.com ORTC announced yesterday that it completed a modest private placement at $15 per share, which is about 10 percent higher than ORTC's 10-day moving average and about 20 percent higher than ORTC's 52-week high as of 3 March 2000. In the past 52 weeks, ORTC has only closed at 15 or higher three times (3 of the past 4 trading sessions); yet it said yesterday that it sold $1 million of equity at $15 per share to a Swiss healthcare fund. ORTC has a number of forthcoming news events, including: (1) On April 1, it will present preliminary data from its venous ulcer trials at an industry conference (Symposium of Advanced Wound Care); (2) Shortly thereafter, ORTC will apply to the FDA to begin pivotal trials for venous ulcers ($1.345 billion/year market); (3) By mid-year, ORTC expects to receive a Humanitarian Device Exemption from the FDA for four "orphan" diseases; (4) In the third quarter, ORTC expects to submit pre-market test data to the FDA for donor-site wounds ($224 million/year market); (5) In the next few months, ORTC expects to release data for preliminary tests for diabetic ulcers ($1.56 billion/year market) and the cryopreserved (frozen) form of its product.Message 12924632 Message 12947248 WCAP holds shares of two forthcoming IPOs (Eprise, week of March 20; ScreamingMedia, late April) and recently participated in financing for China portal etang.com, which has said that it intends to go public this year, and for HomePoint, a B2B that has generated some buzz. Another major WCAP private holding, Vivid Semiconductor, is rumored to be in negotiations with Philips Semi for a potential buyout. WCAP is trading below book value despite the fact that it has a portfolio of 17 private Internet and tech companies that it carries on its balance sheet at cost of investment.biz.yahoo.com eocenter.com